Genitourinary Malignancies: Current Perspectives in Bladder, Kidney, and Testis Cancer
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: August 18, 2005
Conference Dates: Friday, November 4, 2005 Conference Location: The Rittenhouse Hotel, 210 West Rittenhouse Square, Philadelphia, PA
Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania
Conference Objectives: At the completion of this conference, participants should be able to:
Identify risk factors in bladder cancer and how those factors influence treatment options;
Discuss treatment options for patients with advanced bladder disease;
Describe the role of surgical intervention for patients with kidney cancer;
Identify new approaches and data in the treatment of kidney cancer;
Evaluate the role of genetics in patients with testis cancer;
Describe new approaches in the treatment of testis cancer
Who Should Attend: Urologic surgeons, medical oncologists, radiation oncologists, pathologists, hematology oncology fellows, urologic oncology nurses, and other health care professionals involved in the treatment of patients with genitourinary cancer.
8:30-8:40 Welcome and Introduction. S. Bruce Malkowicz, MD
8:40-9:10 Tumor Markers in the Diagnosis and Surveillance of Bladder Cancer. S. Bruce Malkowicz, MD
9:10-9:50 Pathologic Dilemmas in Bladder Cancer. Priti Lal, MD
9:50-10:20 Contemporary Issues in the Treatment of Superficial Bladder Cancer. Michael O'Donnell, MD, FACS
10:30-11:10 Contemporary Management of Muscle Invasive Bladder Cancer. S. Bruce Malkowicz, MD
11:10-11:50 The Role of Systemic Chemotherapy in Invasive Bladder Cancer. David J. Vaughn, MD
1:15-1:45 The Spectrum of Kidney Cancer. John E. Tomaszewski, MD
1:45-2:25 Surgical Management of Renal Cell Carcinoma. Steven C. Campbell, MD, PhD
2:25-3:05 Minimally Invasive Approaches to Small Renal Masses. Timothy W.I. Clark, MD
3:05-3:25 Advances in the Treatment of Metastatic Renal Cell Carcinoma. Keith T. Flaherty, MD
3:45-4:15 The Genetic Aspects of Testis Cancer. Katherine L. Nathanson, MD
4:15-4:55 Contemporary Clinical Care of Testis Cancer. David J. Vaughn, MD
Conference Fees: $190.00 for Physicians; $95.00 for Nurses and other health care professionals, No fee for faculty, staff, fellows at students of University of Pennsylvania
Online Registration: All fields are required.
Make checks payable to: Trustees, University of Pennsylvania. Mail payment and registration to:
Abramson Cancer Center of the University of Pennsylvania
3400 Spruce St. - 16 Penn Tower
Philadelphia, PA 19104-4283
P: 215-662-7328 • F: 215-614-1854
Continuing Education: Yes. The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education: Yes
Miscellany: The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nov 29, 2011 - The incidence of small cell carcinoma of the urinary bladder increased from 1991 to 2005, with elderly Caucasian men being the most commonly affected, according to a study published in the Dec. 1 issue of Cancer.